{"success":true,"data":{"pressRelease":{"id":"134946","rtpr_id":"nBw9fTc3da","ticker":"MTO","exchange":"LSE","all_tickers":["MTO"],"title":"REG-Qube Research & Technologies LTD Form 8.3","author":"Business Wire","published_at":"2026-09-03T11:18:00.131Z","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser: Qube Research & Technologies Limited \n (b) Owner or controller of interests and short positions disclosed, if   \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form Mitie Group plc \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this   \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: 02-09-2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making N/A \n disclosures in respect of any other party to the offer? \n \n \n \n  \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security: 2.5p ordinary \n \n \n \n  \n   Interests Short positions \n \n \n \n  \n Number % Number % \n (1) Relevant securities owned and/or controlled: 0 0.00 0 0.00 \n (2) Cash-settled derivatives: 30,402,897 2.33 0 0.00 \n (3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00 \n purchase/sell: \n TOTAL: 30,402,897 2.33 0 0.00 \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists: 0 \n Details, including nature of the rights concerned and relevant percentages: 0 \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security Purchase/sale Number of securities Price per unit (CCY0) \n \n \n \n  \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (GBp) \n \n \n \n \ne.g. call option \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n position \n 2.5p ordinary equity swap decreasing a long position 1796 209.60 \n 2.5p ordinary equity swap decreasing a long position 68 209.70 \n 2.5p ordinary equity swap decreasing a long position 77169 209.80 \n 2.5p ordinary equity swap decreasing a long position 20309 209.90 \n 2.5p ordinary equity swap decreasing a long position 129829 210.00 \n 2.5p ordinary equity swap decreasing a long position 336 210.10 \n 2.5p ordinary equity swap decreasing a long position 10349 210.20 \n 2.5p ordinary equity swap decreasing a long position 280 210.30 \n 2.5p ordinary equity swap decreasing a long position 11010 210.40 \n 2.5p ordinary equity swap decreasing a short position 32 209.80 \n 2.5p ordinary equity swap decreasing a short position 69 210.00 \n 2.5p ordinary equity swap decreasing a short position 5 210.20 \n 2.5p ordinary equity swap decreasing a short position 3 210.40 \n 2.5p ordinary equity swap increasing a long position 170 209.40 \n 2.5p ordinary equity swap increasing a long position 611 209.80 \n 2.5p ordinary equity swap increasing a long position 136 209.90 \n 2.5p ordinary equity swap increasing a long position 5477 210.00 \n 2.5p ordinary equity swap increasing a long position 499 210.20 \n 2.5p ordinary equity swap increasing a long position 11 210.40 \n 2.5p ordinary equity swap increasing a short position 5355 210.00 \n 2.5p ordinary equity swap increasing a short position 1115 210.20 \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (CCY0) Type Expiry date Option money paid/ received per unit \n \n \n \n \ne.g. American, European etc. \n(CCY0) \n\n\n(ii) Exercise\n Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit \n \n \n \ne.g. call option \n 0 0 0 0 0 \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security Nature of dealing Details Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n 0 0 0 0 \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n Date of disclosure: 03-09-2026 \n Contact name: Janice Falcao \n Telephone number: 00442033140679 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The\nCode can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54598431&newsitemid=20260903978826&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=423c8fb0a5c299a56612e23079411a04)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260903978826/en/\n(https://www.businesswire.com/news/home/20260903978826/en/)\n\nQube Research & Technologies LTD\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw9fTc3da","title":"REG-Qube Research & Technologies LTD Form 8.3","author":"Business Wire","ticker":"MTO","created":"2026-09-03T11:18:00.131Z","tickers":["MTO"],"exchange":"LSE","article_body":"Form 8.3\n\n \n\nFORM 8.3\n\nPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY\n\nA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE\n\nRule 8.3 of the Takeover Code (the “Code”)\n\n1. KEY INFORMATION\n (a) Full name of discloser: Qube Research & Technologies Limited \n (b) Owner or controller of interests and short positions disclosed, if   \n different from 1(a): \n \n \n \nThe naming of nominee or vehicle companies is insufficient. For a trust, the \n trustee(s), settlor and beneficiaries must be named. \n (c) Name of offeror/offeree in relation to whose relevant securities this form Mitie Group plc \n relates: \n \n \n \nUse a separate form for each offeror/offeree \n (d) If an exempt fund manager connected with an offeror/offeree, state this   \n and specify identity of offeror/offeree: \n (e) Date position held/dealing undertaken: 02-09-2026 \n \n \n \nFor an opening position disclosure, state the latest practicable date prior to \n the disclosure \n (f) In addition to the company in 1(c) above, is the discloser making N/A \n disclosures in respect of any other party to the offer? \n \n \n \n  \n \nIf it is a cash offer or possible cash offer, state “N/A” \n\n\n2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE\n\nIf there are positions or rights to subscribe to disclose in more than one\nclass of relevant securities of the offeror or offeree named in 1(c), copy\ntable 2(a) or (b) (as appropriate) for each additional class of relevant\nsecurity.\n\n(a) Interests and short positions in the relevant securities of the offeror or\nofferee to which the disclosure relates following the dealing (if any)\n Class of relevant security: 2.5p ordinary \n \n \n \n  \n   Interests Short positions \n \n \n \n  \n Number % Number % \n (1) Relevant securities owned and/or controlled: 0 0.00 0 0.00 \n (2) Cash-settled derivatives: 30,402,897 2.33 0 0.00 \n (3) Stock-settled derivatives (including options) and agreements to 0 0.00 0 0.00 \n purchase/sell: \n TOTAL: 30,402,897 2.33 0 0.00 \n\n\nAll interests and all short positions should be disclosed.\n\nDetails of any open stock-settled derivative positions (including traded\noptions), or agreements to purchase or sell relevant securities, should be\ngiven on a Supplemental Form 8 (Open Positions).\n\n(b) Rights to subscribe for new securities (including directors’ and other\nemployee options)\n Class of relevant security in relation to which subscription right exists: 0 \n Details, including nature of the rights concerned and relevant percentages: 0 \n\n\n3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE\n\nWhere there have been dealings in more than one class of relevant securities\nof the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as\nappropriate) for each additional class of relevant security dealt in.\n\nThe currency of all prices and other monetary amounts should be stated.\n\n(a) Purchases and sales\n Class of relevant security Purchase/sale Number of securities Price per unit (CCY0) \n \n \n \n  \n\n\n(b) Cash-settled derivative transactions\n Class of relevant security Product description Nature of dealing Number of securities Exercise price per unit (GBp) \n \n \n \n \ne.g. call option \ne.g. opening/closing a long/short position, increasing/reducing a long/short \n position \n 2.5p ordinary equity swap decreasing a long position 1796 209.60 \n 2.5p ordinary equity swap decreasing a long position 68 209.70 \n 2.5p ordinary equity swap decreasing a long position 77169 209.80 \n 2.5p ordinary equity swap decreasing a long position 20309 209.90 \n 2.5p ordinary equity swap decreasing a long position 129829 210.00 \n 2.5p ordinary equity swap decreasing a long position 336 210.10 \n 2.5p ordinary equity swap decreasing a long position 10349 210.20 \n 2.5p ordinary equity swap decreasing a long position 280 210.30 \n 2.5p ordinary equity swap decreasing a long position 11010 210.40 \n 2.5p ordinary equity swap decreasing a short position 32 209.80 \n 2.5p ordinary equity swap decreasing a short position 69 210.00 \n 2.5p ordinary equity swap decreasing a short position 5 210.20 \n 2.5p ordinary equity swap decreasing a short position 3 210.40 \n 2.5p ordinary equity swap increasing a long position 170 209.40 \n 2.5p ordinary equity swap increasing a long position 611 209.80 \n 2.5p ordinary equity swap increasing a long position 136 209.90 \n 2.5p ordinary equity swap increasing a long position 5477 210.00 \n 2.5p ordinary equity swap increasing a long position 499 210.20 \n 2.5p ordinary equity swap increasing a long position 11 210.40 \n 2.5p ordinary equity swap increasing a short position 5355 210.00 \n 2.5p ordinary equity swap increasing a short position 1115 210.20 \n\n\n(c) Stock-settled derivative transactions (including options)\n\n(i) Writing, selling, purchasing or varying\n Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (CCY0) Type Expiry date Option money paid/ received per unit \n \n \n \n \ne.g. American, European etc. \n(CCY0) \n\n\n(ii) Exercise\n Class of relevant security Product description Exercising/ exercised against Number of securities Exercise price per unit \n \n \n \ne.g. call option \n 0 0 0 0 0 \n\n\n(d) Other dealings (including subscribing for new securities)\n Class of relevant security Nature of dealing Details Price per unit (if applicable) \n \n \n \ne.g. subscription, conversion \n 0 0 0 0 \n\n\n4. OTHER INFORMATION\n\n(a) Indemnity and other dealing arrangements\n Details of any indemnity or option arrangement, or any agreement or \n understanding, formal or informal, relating to relevant securities which may \n be an inducement to deal or refrain from dealing entered into by the person \n making the disclosure and any party to the offer or any person acting in \n concert with a party to the offer: \n \n \n \nIrrevocable commitments and letters of intent should not be included. If there \n are no such agreements, arrangements or understandings, state “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(b) Agreements, arrangements or understandings relating to options or\nderivatives\n Details of any agreement, arrangement or understanding, formal or informal, \n between the person making the disclosure and any other person relating to: \n \n \n \n(i) the voting rights of any relevant securities under any option; or \n \n \n \n(ii) the voting rights or future acquisition or disposal of any relevant \n securities to which any derivative is referenced: \n \n \n \nIf there are no such agreements, arrangements or understandings, state \n “none” \n   \n \n \n \nNone \n \n \n \n  \n\n\n(c) Attachments\n Is a Supplemental Form 8 (Open Positions) attached? NO \n\n Date of disclosure: 03-09-2026 \n Contact name: Janice Falcao \n Telephone number: 00442033140679 \n\n\nPublic disclosures under Rule 8 of the Code must be made to a Regulatory\nInformation Service.\n\nThe Panel’s Market Surveillance Unit is available for consultation in\nrelation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The\nCode can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.thetakeoverpanel.org.uk%2F&esheet=54598431&newsitemid=20260903978826&lan=en-US&anchor=www.thetakeoverpanel.org.uk&index=1&md5=423c8fb0a5c299a56612e23079411a04)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260903978826/en/\n(https://www.businesswire.com/news/home/20260903978826/en/)\n\nQube Research & Technologies LTD\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-03T11:18:00.187766548Z","server_sent_at_ms":1788434280187},"received_at":"2026-09-03T11:18:00.357Z","source_url":"https://www.businesswire.com/news/home/20260903978826/en/"},"analysis":{"id":"123834","press_release_id":"134946","analysis_json":{"industry":{"label":"Commercial Services & Supplies","sector":"Industrials"},"redFlags":["Form 8.3 filing implies an active or possible offer situation involving Mitie Group plc, but the form discloses no offeror or offer terms","Entire 2.33% position is held via cash-settled derivatives (equity swaps), not underlying shares, so voting/economic alignment differs from outright ownership","Day's dealing activity skewed toward closing down long swap exposure"],"eventType":"regulatory","narrative":"Qube Research & Technologies Limited filed a Rule 8.3 disclosure under the UK Takeover Code relating to Mitie Group plc, disclosing a position of 30,402,897 shares, equal to 2.33% of relevant securities, held entirely through cash-settled derivatives as of 2 September 2026.\n\nDealing on the day consisted of equity swaps priced between 209.40 and 210.40 pence, predominantly decreasing long positions, with smaller increases on both the long and short side, implying a modest net reduction in Qube's long exposure.\n\nThe form states there are no irrevocable commitments, indemnity arrangements, or derivative voting agreements, and confirms Qube holds no underlying shares. This is a routine compliance filing and contains no new details about the offer situation itself.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine hedge-fund position disclosure in Mitie during an offer period -- useful only for tracking Qube's swap-book positioning shifts, not as a news event."},"keyFigures":{"customDimensions":{"form_type":"Form 8.3 (Takeover Code Rule 8.3)","position_date":"2026-09-02","position_percent":"2.33%","dealing_price_range_gbp":"209.40-210.40 GBp","underlying_shares_owned":0,"cash_settled_derivative_position":30402897}},"namedEntities":{"people":[{"name":"Janice Falcao","role":"disclosure contact, Qube Research & Technologies Limited"}],"products":[],"companies":[{"name":"Qube Research & Technologies Limited","relationship":"discloser (fund manager holding the position)"},{"name":"Mitie Group plc","ticker":"MTO","relationship":"offeror/offeree subject of the disclosure"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine Rule 8.3 UK Takeover Code position disclosure filed by Qube Research & Technologies regarding Mitie Group plc. It reveals a 2.33% cash-settled derivative position and day-of equity-swap dealing, but contains no new information about any offer, its terms, or Mitie's fundamentals."},"tickerRelevance":{"others":[],"primary":"MTO"},"globalImportance":18,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"UK FTSE 250 mid-cap","eventGravity":"routine Takeover Code position disclosure","positionSize":"2.33% via cash-settled derivatives","disclosureType":"Form 8.3 (Rule 8.3 UK Takeover Code)","issuerAuthored":false,"usRetailAudienceAngle":"low -- LSE-listed UK issuer"}},"event_type":"regulatory","event_type_secondary":null,"sentiment":"neutral","material_impact_score":2,"narrative":"Qube Research & Technologies Limited filed a Rule 8.3 disclosure under the UK Takeover Code relating to Mitie Group plc, disclosing a position of 30,402,897 shares, equal to 2.33% of relevant securities, held entirely through cash-settled derivatives as of 2 September 2026.\n\nDealing on the day consisted of equity swaps priced between 209.40 and 210.40 pence, predominantly decreasing long positions, with smaller increases on both the long and short side, implying a modest net reduction in Qube's long exposure.\n\nThe form states there are no irrevocable commitments, indemnity arrangements, or derivative voting agreements, and confirms Qube holds no underlying shares. This is a routine compliance filing and contains no new details about the offer situation itself.","key_figures":{"customDimensions":{"form_type":"Form 8.3 (Takeover Code Rule 8.3)","position_date":"2026-09-02","position_percent":"2.33%","dealing_price_range_gbp":"209.40-210.40 GBp","underlying_shares_owned":0,"cash_settled_derivative_position":30402897}},"named_entities":{"people":[{"name":"Janice Falcao","role":"disclosure contact, Qube Research & Technologies Limited"}],"products":[],"companies":[{"name":"Qube Research & Technologies Limited","relationship":"discloser (fund manager holding the position)"},{"name":"Mitie Group plc","ticker":"MTO","relationship":"offeror/offeree subject of the disclosure"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T11:31:07.455Z","global_importance":18,"audience_relevance":15,"importance_components":{"tickerTier":"UK FTSE 250 mid-cap","eventGravity":"routine Takeover Code position disclosure","positionSize":"2.33% via cash-settled derivatives","disclosureType":"Form 8.3 (Rule 8.3 UK Takeover Code)","issuerAuthored":false,"usRetailAudienceAngle":"low -- LSE-listed UK issuer"}},"durationMs":103983,"modelName":"glm-4.7"}}